Illumina Body Map 2: averaged replicates
Gene Symbol | Gene ID | Gene Info |
---|---|---|
CUX1
|
ENSG00000257923.5 | cut like homeobox 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
CUX1 | hg19_v2_chr7_+_101459263_101459310 | -0.47 | 6.6e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr15_-_22448819 | 6.99 |
ENST00000604066.1
|
IGHV1OR15-1
|
immunoglobulin heavy variable 1/OR15-1 (non-functional) |
chr1_+_161676739 | 6.76 |
ENST00000236938.6
ENST00000367959.2 ENST00000546024.1 ENST00000540521.1 ENST00000367949.2 ENST00000350710.3 ENST00000540926.1 |
FCRLA
|
Fc receptor-like A |
chr1_+_161677034 | 5.92 |
ENST00000349527.4
ENST00000309691.6 ENST00000294796.4 ENST00000367953.3 ENST00000367950.1 |
FCRLA
|
Fc receptor-like A |
chr19_-_7764960 | 5.88 |
ENST00000593418.1
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23) |
chr2_+_7865923 | 5.62 |
ENST00000417930.1
|
AC092580.4
|
AC092580.4 |
chr1_+_161676983 | 4.86 |
ENST00000367957.2
|
FCRLA
|
Fc receptor-like A |
chrX_+_78426469 | 4.66 |
ENST00000276077.1
|
GPR174
|
G protein-coupled receptor 174 |
chr22_+_23241661 | 4.61 |
ENST00000390322.2
|
IGLJ2
|
immunoglobulin lambda joining 2 |
chr1_+_151129103 | 4.49 |
ENST00000368910.3
|
TNFAIP8L2
|
tumor necrosis factor, alpha-induced protein 8-like 2 |
chr11_-_118213360 | 4.45 |
ENST00000529594.1
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex) |
chr14_-_106453155 | 4.28 |
ENST00000390594.2
|
IGHV1-2
|
immunoglobulin heavy variable 1-2 |
chr7_+_142448053 | 4.16 |
ENST00000422143.2
|
TRBV29-1
|
T cell receptor beta variable 29-1 |
chr7_-_142131914 | 4.09 |
ENST00000390375.2
|
TRBV5-6
|
T cell receptor beta variable 5-6 |
chr3_-_112218205 | 3.89 |
ENST00000383680.4
|
BTLA
|
B and T lymphocyte associated |
chr3_-_112218378 | 3.88 |
ENST00000334529.5
|
BTLA
|
B and T lymphocyte associated |
chr7_+_142326335 | 3.70 |
ENST00000390393.3
|
TRBV19
|
T cell receptor beta variable 19 |
chr14_-_106322288 | 3.69 |
ENST00000390559.2
|
IGHM
|
immunoglobulin heavy constant mu |
chr22_+_23077065 | 3.68 |
ENST00000390310.2
|
IGLV2-18
|
immunoglobulin lambda variable 2-18 |
chr22_-_37545972 | 3.52 |
ENST00000216223.5
|
IL2RB
|
interleukin 2 receptor, beta |
chr12_-_55378452 | 3.46 |
ENST00000449076.1
|
TESPA1
|
thymocyte expressed, positive selection associated 1 |
chr19_-_10628117 | 3.25 |
ENST00000333430.4
|
S1PR5
|
sphingosine-1-phosphate receptor 5 |
chr2_+_90259593 | 3.10 |
ENST00000471857.1
|
IGKV1D-8
|
immunoglobulin kappa variable 1D-8 |
chr6_+_31554962 | 3.09 |
ENST00000376092.3
ENST00000376086.3 ENST00000303757.8 ENST00000376093.2 ENST00000376102.3 |
LST1
|
leukocyte specific transcript 1 |
chr2_+_90139056 | 3.08 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
chr22_+_22786288 | 3.07 |
ENST00000390301.2
|
IGLV1-36
|
immunoglobulin lambda variable 1-36 |
chr6_+_31554826 | 3.02 |
ENST00000376089.2
ENST00000396112.2 |
LST1
|
leukocyte specific transcript 1 |
chr5_-_66492562 | 2.94 |
ENST00000256447.4
|
CD180
|
CD180 molecule |
chr14_-_106331652 | 2.92 |
ENST00000390565.1
|
IGHJ1
|
immunoglobulin heavy joining 1 |
chr2_-_89278535 | 2.92 |
ENST00000390247.2
|
IGKV3-7
|
immunoglobulin kappa variable 3-7 (non-functional) |
chr2_+_90153696 | 2.91 |
ENST00000417279.2
|
IGKV3D-15
|
immunoglobulin kappa variable 3D-15 (gene/pseudogene) |
chr22_+_23235872 | 2.91 |
ENST00000390320.2
|
IGLJ1
|
immunoglobulin lambda joining 1 |
chr11_+_118175596 | 2.91 |
ENST00000528600.1
|
CD3E
|
CD3e molecule, epsilon (CD3-TCR complex) |
chr1_-_157670528 | 2.89 |
ENST00000368186.5
ENST00000496769.1 |
FCRL3
|
Fc receptor-like 3 |
chr14_-_106330458 | 2.88 |
ENST00000461719.1
|
IGHJ4
|
immunoglobulin heavy joining 4 |
chr22_+_22712087 | 2.86 |
ENST00000390294.2
|
IGLV1-47
|
immunoglobulin lambda variable 1-47 |
chr14_-_106092403 | 2.85 |
ENST00000390543.2
|
IGHG4
|
immunoglobulin heavy constant gamma 4 (G4m marker) |
chr12_-_53601000 | 2.80 |
ENST00000338737.4
ENST00000549086.2 |
ITGB7
|
integrin, beta 7 |
chr11_-_111320706 | 2.76 |
ENST00000531398.1
|
POU2AF1
|
POU class 2 associating factor 1 |
chr22_+_22697537 | 2.72 |
ENST00000427632.2
|
IGLV9-49
|
immunoglobulin lambda variable 9-49 |
chr16_+_32859034 | 2.68 |
ENST00000567458.2
ENST00000560724.1 |
IGHV2OR16-5
|
immunoglobulin heavy variable 2/OR16-5 (non-functional) |
chr11_+_118175132 | 2.67 |
ENST00000361763.4
|
CD3E
|
CD3e molecule, epsilon (CD3-TCR complex) |
chrX_-_70331298 | 2.61 |
ENST00000456850.2
ENST00000473378.1 ENST00000487883.1 ENST00000374202.2 |
IL2RG
|
interleukin 2 receptor, gamma |
chr2_+_90229045 | 2.61 |
ENST00000390278.2
|
IGKV1D-42
|
immunoglobulin kappa variable 1D-42 (non-functional) |
chr1_-_27953031 | 2.53 |
ENST00000374003.3
|
FGR
|
feline Gardner-Rasheed sarcoma viral oncogene homolog |
chr14_-_107283278 | 2.52 |
ENST00000390639.2
|
IGHV7-81
|
immunoglobulin heavy variable 7-81 (non-functional) |
chr22_+_23243156 | 2.51 |
ENST00000390323.2
|
IGLC2
|
immunoglobulin lambda constant 2 (Kern-Oz- marker) |
chr7_-_142139783 | 2.43 |
ENST00000390374.3
|
TRBV7-6
|
T cell receptor beta variable 7-6 |
chr7_-_142207004 | 2.43 |
ENST00000426318.2
|
TRBV10-2
|
T cell receptor beta variable 10-2 |
chr7_+_142378566 | 2.41 |
ENST00000390398.3
|
TRBV25-1
|
T cell receptor beta variable 25-1 |
chr7_-_142176790 | 2.41 |
ENST00000390369.2
|
TRBV7-4
|
T cell receptor beta variable 7-4 (gene/pseudogene) |
chr19_-_42133420 | 2.38 |
ENST00000221954.2
ENST00000600925.1 |
CEACAM4
|
carcinoembryonic antigen-related cell adhesion molecule 4 |
chr7_+_142031986 | 2.37 |
ENST00000547918.2
|
TRBV7-1
|
T cell receptor beta variable 7-1 (non-functional) |
chr16_+_27413483 | 2.31 |
ENST00000337929.3
ENST00000564089.1 |
IL21R
|
interleukin 21 receptor |
chr14_+_22788560 | 2.29 |
ENST00000390468.1
|
TRAV41
|
T cell receptor alpha variable 41 |
chr17_-_38721711 | 2.24 |
ENST00000578085.1
ENST00000246657.2 |
CCR7
|
chemokine (C-C motif) receptor 7 |
chr17_-_43502987 | 2.21 |
ENST00000376922.2
|
ARHGAP27
|
Rho GTPase activating protein 27 |
chr19_-_51875523 | 2.19 |
ENST00000593572.1
ENST00000595157.1 |
NKG7
|
natural killer cell group 7 sequence |
chr22_+_22676808 | 2.16 |
ENST00000390290.2
|
IGLV1-51
|
immunoglobulin lambda variable 1-51 |
chr7_+_142012967 | 2.15 |
ENST00000390357.3
|
TRBV4-1
|
T cell receptor beta variable 4-1 |
chr14_-_106725723 | 2.15 |
ENST00000390609.2
|
IGHV3-23
|
immunoglobulin heavy variable 3-23 |
chr2_-_158300556 | 2.11 |
ENST00000264192.3
|
CYTIP
|
cytohesin 1 interacting protein |
chr22_+_22385332 | 2.09 |
ENST00000390282.2
|
IGLV4-69
|
immunoglobulin lambda variable 4-69 |
chr4_-_48136217 | 2.09 |
ENST00000264316.4
|
TXK
|
TXK tyrosine kinase |
chr1_-_36948879 | 2.08 |
ENST00000373106.1
ENST00000373104.1 ENST00000373103.1 |
CSF3R
|
colony stimulating factor 3 receptor (granulocyte) |
chr11_-_58980342 | 2.08 |
ENST00000361050.3
|
MPEG1
|
macrophage expressed 1 |
chr7_-_142198049 | 2.07 |
ENST00000471935.1
|
TRBV11-2
|
T cell receptor beta variable 11-2 |
chr22_-_37640277 | 2.07 |
ENST00000401529.3
ENST00000249071.6 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr22_+_23165153 | 2.05 |
ENST00000390317.2
|
IGLV2-8
|
immunoglobulin lambda variable 2-8 |
chr12_+_7060508 | 2.05 |
ENST00000541698.1
ENST00000542462.1 |
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6 |
chr13_-_28674693 | 2.04 |
ENST00000537084.1
ENST00000241453.7 ENST00000380982.4 |
FLT3
|
fms-related tyrosine kinase 3 |
chr11_+_67171548 | 2.03 |
ENST00000542590.1
|
TBC1D10C
|
TBC1 domain family, member 10C |
chr14_-_25045446 | 2.03 |
ENST00000216336.2
|
CTSG
|
cathepsin G |
chr22_+_22730353 | 2.00 |
ENST00000390296.2
|
IGLV5-45
|
immunoglobulin lambda variable 5-45 |
chr16_+_33006369 | 1.98 |
ENST00000425181.3
|
IGHV3OR16-10
|
immunoglobulin heavy variable 3/OR16-10 (non-functional) |
chr14_+_22965872 | 1.97 |
ENST00000390495.1
|
TRAJ42
|
T cell receptor alpha joining 42 |
chr13_-_46716969 | 1.97 |
ENST00000435666.2
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin) |
chr14_-_106068065 | 1.96 |
ENST00000390541.2
|
IGHE
|
immunoglobulin heavy constant epsilon |
chr12_-_55378470 | 1.95 |
ENST00000524668.1
ENST00000533607.1 |
TESPA1
|
thymocyte expressed, positive selection associated 1 |
chr14_+_22771851 | 1.94 |
ENST00000390466.1
|
TRAV39
|
T cell receptor alpha variable 39 |
chr19_-_10450328 | 1.94 |
ENST00000160262.5
|
ICAM3
|
intercellular adhesion molecule 3 |
chr22_+_23040274 | 1.93 |
ENST00000390306.2
|
IGLV2-23
|
immunoglobulin lambda variable 2-23 |
chr12_+_7060414 | 1.93 |
ENST00000538715.1
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6 |
chr6_-_159466136 | 1.89 |
ENST00000367066.3
ENST00000326965.6 |
TAGAP
|
T-cell activation RhoGTPase activating protein |
chr7_-_142120321 | 1.86 |
ENST00000390377.1
|
TRBV7-7
|
T cell receptor beta variable 7-7 |
chr14_+_23009190 | 1.84 |
ENST00000390532.1
|
TRAJ5
|
T cell receptor alpha joining 5 |
chr12_+_8666126 | 1.84 |
ENST00000299665.2
|
CLEC4D
|
C-type lectin domain family 4, member D |
chr14_-_65785502 | 1.84 |
ENST00000553754.1
|
CTD-2509G16.5
|
CTD-2509G16.5 |
chr7_-_38403077 | 1.84 |
ENST00000426402.2
|
TRGV2
|
T cell receptor gamma variable 2 |
chr19_-_54784353 | 1.84 |
ENST00000391746.1
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 |
chr2_-_113594279 | 1.83 |
ENST00000416750.1
ENST00000418817.1 ENST00000263341.2 |
IL1B
|
interleukin 1, beta |
chr14_-_25103388 | 1.83 |
ENST00000526004.1
ENST00000415355.3 |
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
chr1_+_158901329 | 1.83 |
ENST00000368140.1
ENST00000368138.3 ENST00000392254.2 ENST00000392252.3 ENST00000368135.4 |
PYHIN1
|
pyrin and HIN domain family, member 1 |
chr12_+_7060432 | 1.83 |
ENST00000318974.9
ENST00000456013.1 |
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6 |
chr12_+_86268065 | 1.83 |
ENST00000551529.1
ENST00000256010.6 |
NTS
|
neurotensin |
chr1_-_151032040 | 1.83 |
ENST00000540998.1
ENST00000357235.5 |
CDC42SE1
|
CDC42 small effector 1 |
chr22_+_22516550 | 1.82 |
ENST00000390284.2
|
IGLV4-60
|
immunoglobulin lambda variable 4-60 |
chr12_-_54689532 | 1.82 |
ENST00000540264.2
ENST00000312156.4 |
NFE2
|
nuclear factor, erythroid 2 |
chr1_+_206730484 | 1.77 |
ENST00000304534.8
|
RASSF5
|
Ras association (RalGDS/AF-6) domain family member 5 |
chr4_-_48116540 | 1.77 |
ENST00000506073.1
|
TXK
|
TXK tyrosine kinase |
chr16_-_85784634 | 1.77 |
ENST00000284245.4
ENST00000602914.1 |
C16orf74
|
chromosome 16 open reading frame 74 |
chr7_-_142224280 | 1.76 |
ENST00000390367.3
|
TRBV11-1
|
T cell receptor beta variable 11-1 |
chr6_-_159466042 | 1.75 |
ENST00000338313.5
|
TAGAP
|
T-cell activation RhoGTPase activating protein |
chr17_-_72358001 | 1.71 |
ENST00000375366.3
|
BTBD17
|
BTB (POZ) domain containing 17 |
chr7_+_142364193 | 1.71 |
ENST00000390397.2
|
TRBV24-1
|
T cell receptor beta variable 24-1 |
chr7_-_3083573 | 1.70 |
ENST00000396946.4
|
CARD11
|
caspase recruitment domain family, member 11 |
chr17_-_47287928 | 1.70 |
ENST00000507680.1
|
GNGT2
|
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2 |
chr16_+_27438563 | 1.69 |
ENST00000395754.4
|
IL21R
|
interleukin 21 receptor |
chr21_+_10862622 | 1.66 |
ENST00000302092.5
ENST00000559480.1 |
IGHV1OR21-1
|
immunoglobulin heavy variable 1/OR21-1 (non-functional) |
chr1_-_27952617 | 1.65 |
ENST00000457296.1
|
FGR
|
feline Gardner-Rasheed sarcoma viral oncogene homolog |
chr17_-_72542278 | 1.64 |
ENST00000330793.1
|
CD300C
|
CD300c molecule |
chr19_+_55084438 | 1.64 |
ENST00000439534.1
|
LILRA2
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 |
chr11_-_118095718 | 1.64 |
ENST00000526620.1
|
AMICA1
|
adhesion molecule, interacts with CXADR antigen 1 |
chr22_+_50986462 | 1.64 |
ENST00000395676.2
|
KLHDC7B
|
kelch domain containing 7B |
chr19_-_10450287 | 1.63 |
ENST00000589261.1
ENST00000590569.1 ENST00000589580.1 ENST00000589249.1 |
ICAM3
|
intercellular adhesion molecule 3 |
chr11_-_118095801 | 1.63 |
ENST00000356289.5
|
AMICA1
|
adhesion molecule, interacts with CXADR antigen 1 |
chr9_+_130478345 | 1.63 |
ENST00000373289.3
ENST00000393748.4 |
TTC16
|
tetratricopeptide repeat domain 16 |
chr14_+_22970526 | 1.61 |
ENST00000390498.1
|
TRAJ39
|
T cell receptor alpha joining 39 |
chr5_+_57787254 | 1.60 |
ENST00000502276.1
ENST00000396776.2 ENST00000511930.1 |
GAPT
|
GRB2-binding adaptor protein, transmembrane |
chr7_-_1980128 | 1.60 |
ENST00000437877.1
|
MAD1L1
|
MAD1 mitotic arrest deficient-like 1 (yeast) |
chr15_-_31523036 | 1.59 |
ENST00000559094.1
ENST00000558388.2 |
RP11-16E12.2
|
RP11-16E12.2 |
chr17_-_7018128 | 1.59 |
ENST00000380952.2
ENST00000254850.7 |
ASGR2
|
asialoglycoprotein receptor 2 |
chr16_+_31366536 | 1.59 |
ENST00000562522.1
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit) |
chr9_-_136344237 | 1.59 |
ENST00000432868.1
ENST00000371899.4 |
SLC2A6
|
solute carrier family 2 (facilitated glucose transporter), member 6 |
chr14_+_21359558 | 1.58 |
ENST00000304639.3
|
RNASE3
|
ribonuclease, RNase A family, 3 |
chr1_-_27952741 | 1.58 |
ENST00000399173.1
|
FGR
|
feline Gardner-Rasheed sarcoma viral oncogene homolog |
chr17_-_7017968 | 1.56 |
ENST00000355035.5
|
ASGR2
|
asialoglycoprotein receptor 2 |
chr5_-_156362666 | 1.55 |
ENST00000406964.1
|
TIMD4
|
T-cell immunoglobulin and mucin domain containing 4 |
chr11_+_67171358 | 1.54 |
ENST00000526387.1
|
TBC1D10C
|
TBC1 domain family, member 10C |
chr7_-_142251148 | 1.53 |
ENST00000390360.3
|
TRBV6-4
|
T cell receptor beta variable 6-4 |
chr19_+_55085248 | 1.51 |
ENST00000391738.3
ENST00000251376.3 ENST00000391737.1 ENST00000396321.2 ENST00000418536.2 ENST00000448689.1 |
LILRA2
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
chr2_+_28853443 | 1.51 |
ENST00000436775.1
|
PLB1
|
phospholipase B1 |
chr2_-_158182410 | 1.49 |
ENST00000419116.2
ENST00000410096.1 |
ERMN
|
ermin, ERM-like protein |
chr18_-_67629015 | 1.47 |
ENST00000579496.1
|
CD226
|
CD226 molecule |
chr14_+_22971215 | 1.47 |
ENST00000390499.1
|
TRAJ38
|
T cell receptor alpha joining 38 |
chr8_+_27168988 | 1.44 |
ENST00000397501.1
ENST00000338238.4 ENST00000544172.1 |
PTK2B
|
protein tyrosine kinase 2 beta |
chr6_+_391739 | 1.41 |
ENST00000380956.4
|
IRF4
|
interferon regulatory factor 4 |
chrX_-_30595959 | 1.41 |
ENST00000378962.3
|
CXorf21
|
chromosome X open reading frame 21 |
chr14_+_22987424 | 1.41 |
ENST00000390511.1
|
TRAJ26
|
T cell receptor alpha joining 26 |
chr2_-_96811170 | 1.41 |
ENST00000288943.4
|
DUSP2
|
dual specificity phosphatase 2 |
chr5_-_131826457 | 1.40 |
ENST00000437654.1
ENST00000245414.4 |
IRF1
|
interferon regulatory factor 1 |
chr9_-_136344197 | 1.40 |
ENST00000414172.1
ENST00000371897.4 |
SLC2A6
|
solute carrier family 2 (facilitated glucose transporter), member 6 |
chr17_-_74489215 | 1.40 |
ENST00000585701.1
ENST00000591192.1 ENST00000589526.1 |
RHBDF2
|
rhomboid 5 homolog 2 (Drosophila) |
chr19_-_54876414 | 1.39 |
ENST00000474878.1
ENST00000348231.4 |
LAIR1
|
leukocyte-associated immunoglobulin-like receptor 1 |
chr12_-_21487829 | 1.38 |
ENST00000445053.1
ENST00000452078.1 ENST00000458504.1 ENST00000422327.1 ENST00000421294.1 |
SLCO1A2
|
solute carrier organic anion transporter family, member 1A2 |
chr14_+_22636283 | 1.35 |
ENST00000557168.1
|
TRAV30
|
T cell receptor alpha variable 30 |
chr1_+_156117149 | 1.34 |
ENST00000435124.1
|
SEMA4A
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
chr6_+_36973406 | 1.34 |
ENST00000274963.8
|
FGD2
|
FYVE, RhoGEF and PH domain containing 2 |
chr19_+_35645817 | 1.34 |
ENST00000423817.3
|
FXYD5
|
FXYD domain containing ion transport regulator 5 |
chr1_+_158801095 | 1.33 |
ENST00000368141.4
|
MNDA
|
myeloid cell nuclear differentiation antigen |
chrX_+_48542168 | 1.33 |
ENST00000376701.4
|
WAS
|
Wiskott-Aldrich syndrome |
chr17_-_18950310 | 1.32 |
ENST00000573099.1
|
GRAP
|
GRB2-related adaptor protein |
chr6_-_32498046 | 1.32 |
ENST00000374975.3
|
HLA-DRB5
|
major histocompatibility complex, class II, DR beta 5 |
chr13_-_46961317 | 1.32 |
ENST00000322896.6
|
KIAA0226L
|
KIAA0226-like |
chr6_+_32811861 | 1.32 |
ENST00000453426.1
|
TAPSAR1
|
TAP1 and PSMB8 antisense RNA 1 |
chr1_+_156119798 | 1.31 |
ENST00000355014.2
|
SEMA4A
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
chr17_+_42427826 | 1.30 |
ENST00000586443.1
|
GRN
|
granulin |
chr5_-_157002749 | 1.29 |
ENST00000517905.1
ENST00000430702.2 ENST00000394020.1 |
ADAM19
|
ADAM metallopeptidase domain 19 |
chr5_-_131347583 | 1.29 |
ENST00000379255.1
ENST00000430403.1 ENST00000544770.1 ENST00000379246.1 ENST00000414078.1 ENST00000441995.1 |
ACSL6
|
acyl-CoA synthetase long-chain family member 6 |
chr22_+_37318082 | 1.27 |
ENST00000406230.1
|
CSF2RB
|
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) |
chr17_+_19030782 | 1.27 |
ENST00000344415.4
ENST00000577213.1 |
GRAPL
|
GRB2-related adaptor protein-like |
chr7_+_74188309 | 1.27 |
ENST00000289473.4
ENST00000433458.1 |
NCF1
|
neutrophil cytosolic factor 1 |
chr11_+_62037622 | 1.27 |
ENST00000227918.2
ENST00000525380.1 |
SCGB2A2
|
secretoglobin, family 2A, member 2 |
chr12_+_7055631 | 1.27 |
ENST00000543115.1
ENST00000399448.1 |
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6 |
chr19_+_51630287 | 1.26 |
ENST00000599948.1
|
SIGLEC9
|
sialic acid binding Ig-like lectin 9 |
chr6_+_36683256 | 1.26 |
ENST00000229824.8
|
RAB44
|
RAB44, member RAS oncogene family |
chr7_+_26191809 | 1.25 |
ENST00000056233.3
|
NFE2L3
|
nuclear factor, erythroid 2-like 3 |
chr10_-_14613968 | 1.25 |
ENST00000488576.1
ENST00000472095.1 |
FAM107B
|
family with sequence similarity 107, member B |
chr3_+_172361483 | 1.24 |
ENST00000598405.1
|
AC007919.2
|
HCG1787166; PRO1163; Uncharacterized protein |
chr3_+_142842128 | 1.24 |
ENST00000483262.1
|
RP11-80H8.4
|
RP11-80H8.4 |
chr10_-_98480243 | 1.23 |
ENST00000339364.5
|
PIK3AP1
|
phosphoinositide-3-kinase adaptor protein 1 |
chr2_-_158182322 | 1.22 |
ENST00000420719.2
ENST00000409216.1 |
ERMN
|
ermin, ERM-like protein |
chr19_-_54604083 | 1.22 |
ENST00000391761.1
ENST00000356532.3 ENST00000359649.4 ENST00000358375.4 ENST00000391760.1 ENST00000351806.4 |
OSCAR
|
osteoclast associated, immunoglobulin-like receptor |
chr5_-_157002775 | 1.21 |
ENST00000257527.4
|
ADAM19
|
ADAM metallopeptidase domain 19 |
chr13_+_30510003 | 1.18 |
ENST00000400540.1
|
LINC00544
|
long intergenic non-protein coding RNA 544 |
chr1_+_48688357 | 1.17 |
ENST00000533824.1
ENST00000438567.2 ENST00000236495.5 ENST00000420136.2 |
SLC5A9
|
solute carrier family 5 (sodium/sugar cotransporter), member 9 |
chr7_-_36764062 | 1.17 |
ENST00000435386.1
|
AOAH
|
acyloxyacyl hydrolase (neutrophil) |
chr11_+_36317830 | 1.15 |
ENST00000530639.1
|
PRR5L
|
proline rich 5 like |
chr12_+_6898674 | 1.14 |
ENST00000541982.1
ENST00000539492.1 |
CD4
|
CD4 molecule |
chr1_-_183560011 | 1.14 |
ENST00000367536.1
|
NCF2
|
neutrophil cytosolic factor 2 |
chr1_+_111773349 | 1.13 |
ENST00000533831.2
|
CHI3L2
|
chitinase 3-like 2 |
chr1_-_156786634 | 1.13 |
ENST00000392306.2
ENST00000368199.3 |
SH2D2A
|
SH2 domain containing 2A |
chr17_-_5487768 | 1.12 |
ENST00000269280.4
ENST00000345221.3 ENST00000262467.5 |
NLRP1
|
NLR family, pyrin domain containing 1 |
chr20_+_58571419 | 1.11 |
ENST00000244049.3
ENST00000350849.6 ENST00000456106.1 |
CDH26
|
cadherin 26 |
chr19_+_5681153 | 1.11 |
ENST00000579559.1
ENST00000577222.1 |
HSD11B1L
RPL36
|
hydroxysteroid (11-beta) dehydrogenase 1-like ribosomal protein L36 |
chr14_-_106963409 | 1.11 |
ENST00000390621.2
|
IGHV1-45
|
immunoglobulin heavy variable 1-45 |
chr11_+_35222629 | 1.11 |
ENST00000526553.1
|
CD44
|
CD44 molecule (Indian blood group) |
chr19_-_54824344 | 1.10 |
ENST00000346508.3
ENST00000446712.3 ENST00000432233.3 ENST00000301219.3 |
LILRA5
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 |
chr10_-_14614122 | 1.09 |
ENST00000378465.3
ENST00000452706.2 ENST00000378458.2 |
FAM107B
|
family with sequence similarity 107, member B |
chr5_+_176784837 | 1.08 |
ENST00000408923.3
|
RGS14
|
regulator of G-protein signaling 14 |
chr16_-_776431 | 1.07 |
ENST00000293889.6
|
CCDC78
|
coiled-coil domain containing 78 |
chrX_-_47489244 | 1.06 |
ENST00000469388.1
ENST00000396992.3 ENST00000377005.2 |
CFP
|
complement factor properdin |
chr6_-_32820529 | 1.05 |
ENST00000425148.2
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
chr5_-_149465990 | 1.05 |
ENST00000543093.1
|
CSF1R
|
colony stimulating factor 1 receptor |
chr17_+_6900201 | 1.04 |
ENST00000480801.1
|
ALOX12
|
arachidonate 12-lipoxygenase |
chr6_-_32812420 | 1.04 |
ENST00000374881.2
|
PSMB8
|
proteasome (prosome, macropain) subunit, beta type, 8 |
chr6_+_31554612 | 1.04 |
ENST00000211921.7
|
LST1
|
leukocyte specific transcript 1 |
chr7_-_139727118 | 1.03 |
ENST00000484111.1
|
PARP12
|
poly (ADP-ribose) polymerase family, member 12 |
chr10_-_14614095 | 1.03 |
ENST00000482277.1
ENST00000378462.1 |
FAM107B
|
family with sequence similarity 107, member B |
chr19_-_10628098 | 1.03 |
ENST00000590601.1
|
S1PR5
|
sphingosine-1-phosphate receptor 5 |
chr1_+_161632937 | 1.03 |
ENST00000236937.9
ENST00000367961.4 ENST00000358671.5 |
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 7.1 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
1.1 | 5.6 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
1.0 | 5.9 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.9 | 1.8 | GO:0060557 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
0.9 | 2.6 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.9 | 2.6 | GO:0043317 | regulation of cytotoxic T cell degranulation(GO:0043317) negative regulation of cytotoxic T cell degranulation(GO:0043318) |
0.8 | 5.4 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.8 | 6.1 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.7 | 2.2 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.6 | 4.5 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.6 | 3.9 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.6 | 1.8 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
0.6 | 2.8 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.5 | 2.6 | GO:0031296 | B cell costimulation(GO:0031296) |
0.5 | 1.4 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.5 | 1.4 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.4 | 3.4 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
0.4 | 1.1 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
0.4 | 3.6 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.3 | 28.5 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.3 | 2.0 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.3 | 1.3 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
0.3 | 7.1 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.3 | 4.3 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.3 | 1.1 | GO:0035397 | helper T cell enhancement of adaptive immune response(GO:0035397) |
0.3 | 2.3 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.3 | 1.1 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.3 | 1.3 | GO:0038156 | interleukin-5-mediated signaling pathway(GO:0038043) interleukin-3-mediated signaling pathway(GO:0038156) |
0.3 | 0.8 | GO:1901656 | glycoside transport(GO:1901656) |
0.2 | 1.5 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.2 | 1.9 | GO:0070944 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) |
0.2 | 1.0 | GO:0060032 | notochord regression(GO:0060032) |
0.2 | 0.7 | GO:0061582 | colon epithelial cell migration(GO:0061580) intestinal epithelial cell migration(GO:0061582) |
0.2 | 0.7 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.2 | 1.8 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.2 | 4.9 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.2 | 1.1 | GO:0035150 | regulation of tube size(GO:0035150) regulation of blood vessel size(GO:0050880) |
0.2 | 1.1 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.2 | 1.4 | GO:2000538 | regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
0.2 | 1.6 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.2 | 1.4 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.2 | 1.4 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.2 | 1.2 | GO:0048690 | regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
0.2 | 0.7 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.2 | 3.9 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.2 | 1.2 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.2 | 0.9 | GO:0071400 | cellular response to oleic acid(GO:0071400) |
0.2 | 1.0 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) regulation of natural killer cell differentiation involved in immune response(GO:0032826) regulation of extrathymic T cell differentiation(GO:0033082) |
0.2 | 0.7 | GO:0003363 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
0.2 | 1.0 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.2 | 2.6 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.2 | 0.8 | GO:0002399 | MHC class II protein complex assembly(GO:0002399) |
0.2 | 33.9 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.2 | 0.8 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
0.1 | 0.7 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.1 | 0.6 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.1 | 1.4 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.1 | 1.0 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 1.5 | GO:0032264 | IMP salvage(GO:0032264) |
0.1 | 0.7 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.1 | 1.1 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.9 | GO:0019556 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.1 | 1.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.1 | 0.6 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 | 0.6 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.1 | 0.7 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 11.8 | GO:0050672 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
0.1 | 1.4 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.1 | 1.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 1.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.8 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 5.2 | GO:0050868 | negative regulation of T cell activation(GO:0050868) |
0.1 | 1.7 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 1.4 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 0.8 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
0.1 | 1.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 4.6 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.1 | 1.0 | GO:1904970 | brush border assembly(GO:1904970) |
0.1 | 0.6 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.1 | 0.6 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.1 | 2.4 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.1 | 0.9 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 10.7 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.1 | 1.2 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.4 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
0.1 | 2.2 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.3 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.1 | 1.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.7 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.1 | 0.6 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.1 | 0.7 | GO:1901297 | positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
0.1 | 0.6 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 9.6 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
0.1 | 0.3 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.1 | 0.3 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
0.1 | 0.8 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 | 0.3 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.1 | 3.5 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.1 | 0.5 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
0.1 | 1.1 | GO:0090197 | regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
0.1 | 0.3 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
0.1 | 0.3 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.1 | 0.3 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.1 | 0.8 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.2 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
0.1 | 0.2 | GO:0046041 | ITP metabolic process(GO:0046041) |
0.1 | 1.1 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 1.0 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.4 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 0.7 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.1 | 0.2 | GO:0097254 | renal tubular secretion(GO:0097254) |
0.1 | 0.5 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.1 | 0.2 | GO:0032747 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.3 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.1 | 0.2 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.1 | 0.4 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.1 | 0.1 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 0.5 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.6 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.1 | 1.0 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.3 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.1 | 1.1 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 2.0 | GO:0097186 | amelogenesis(GO:0097186) |
0.1 | 1.8 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.1 | 0.4 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.0 | 0.5 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.0 | 0.5 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
0.0 | 1.2 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.4 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.0 | 0.7 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.0 | 0.4 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.0 | 0.3 | GO:0034959 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.0 | 0.4 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.0 | 0.2 | GO:1990523 | bone regeneration(GO:1990523) |
0.0 | 0.8 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.7 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.0 | 0.4 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.9 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 8.3 | GO:0002223 | stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
0.0 | 0.6 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.2 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.0 | 0.8 | GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) |
0.0 | 0.1 | GO:1902559 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
0.0 | 0.1 | GO:0070839 | spleen trabecula formation(GO:0060345) divalent metal ion export(GO:0070839) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
0.0 | 4.0 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.0 | 9.4 | GO:0002250 | adaptive immune response(GO:0002250) |
0.0 | 0.5 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.0 | 0.6 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.0 | 0.9 | GO:0002449 | lymphocyte mediated immunity(GO:0002449) |
0.0 | 0.7 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 2.3 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 1.8 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 1.4 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.2 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.0 | 0.3 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.0 | 0.2 | GO:0034127 | regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034127) negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
0.0 | 0.3 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.0 | 0.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.2 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.0 | 0.0 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
0.0 | 0.3 | GO:0097466 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.0 | 0.1 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
0.0 | 0.2 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.0 | 0.1 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.0 | 0.2 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.0 | 0.2 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.0 | 0.1 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.2 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.0 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.4 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.0 | 0.3 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.0 | 2.8 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.4 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.0 | 1.7 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.0 | 0.1 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.0 | 0.2 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
0.0 | 0.4 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.3 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.4 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.0 | 0.4 | GO:0060056 | mammary gland involution(GO:0060056) |
0.0 | 0.3 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.0 | 0.2 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
0.0 | 0.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.0 | 0.3 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.0 | 0.6 | GO:0032225 | regulation of synaptic transmission, dopaminergic(GO:0032225) |
0.0 | 0.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.3 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.0 | 0.4 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 1.1 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.0 | 0.2 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.0 | 0.3 | GO:2000288 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) positive regulation of myoblast proliferation(GO:2000288) |
0.0 | 0.4 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.0 | 0.2 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.4 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.2 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.0 | 1.5 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.2 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 0.1 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.0 | 0.2 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.0 | 0.9 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.0 | 0.2 | GO:1901660 | calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
0.0 | 0.8 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.0 | 0.3 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.9 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.0 | 1.3 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
0.0 | 0.2 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.0 | 1.3 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.1 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.0 | 0.7 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.1 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.0 | 0.3 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.1 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.0 | 0.1 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.0 | 0.4 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.0 | 0.1 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.0 | 0.9 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.0 | 0.2 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.2 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.0 | 0.6 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.6 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.0 | 1.5 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.0 | 0.9 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.2 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.4 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.0 | 0.2 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.0 | 0.3 | GO:1901663 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.0 | 0.5 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.3 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.5 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.5 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.0 | 0.3 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.1 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.0 | 0.6 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.0 | GO:0018969 | thiocyanate metabolic process(GO:0018969) |
0.0 | 0.2 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.0 | 0.3 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.1 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.0 | 0.0 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.0 | 0.6 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.6 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 17.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.6 | 2.8 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.5 | 25.9 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.4 | 1.3 | GO:0030526 | granulocyte macrophage colony-stimulating factor receptor complex(GO:0030526) |
0.3 | 3.1 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.3 | 1.0 | GO:0032998 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
0.3 | 1.1 | GO:0072534 | perineuronal net(GO:0072534) |
0.2 | 1.7 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.2 | 2.4 | GO:0032010 | phagolysosome(GO:0032010) |
0.2 | 3.1 | GO:0033269 | internode region of axon(GO:0033269) |
0.2 | 1.6 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.2 | 1.1 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.2 | 1.1 | GO:0098536 | deuterosome(GO:0098536) |
0.2 | 1.1 | GO:0042825 | TAP complex(GO:0042825) |
0.2 | 1.1 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.1 | 2.9 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 3.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.5 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.1 | 0.6 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.1 | 0.7 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.1 | 0.9 | GO:0035976 | AP1 complex(GO:0035976) |
0.1 | 0.7 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 0.3 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 0.3 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.1 | 5.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 1.2 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 8.6 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.1 | 1.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 0.3 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.1 | 0.7 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 4.9 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 2.0 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 7.9 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.1 | 21.1 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 1.0 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 1.0 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 1.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.4 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.0 | 0.2 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
0.0 | 0.3 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.0 | 0.7 | GO:0044327 | dendritic spine head(GO:0044327) |
0.0 | 0.3 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 1.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.3 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.0 | 1.4 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 3.1 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 1.4 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.0 | 0.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.4 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.2 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 0.5 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 0.2 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.0 | 0.3 | GO:0033503 | HULC complex(GO:0033503) |
0.0 | 0.4 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.1 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
0.0 | 0.6 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 1.1 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 5.6 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 0.6 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.0 | 0.6 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.8 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.6 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.2 | GO:0042627 | chylomicron(GO:0042627) |
0.0 | 1.8 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 0.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.3 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 3.7 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.3 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 1.1 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 0.5 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.0 | 0.2 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.0 | 0.3 | GO:0070938 | contractile ring(GO:0070938) |
0.0 | 0.2 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 0.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 0.1 | GO:0005602 | complement component C1 complex(GO:0005602) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 1.8 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 1.3 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 1.4 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.7 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 0.3 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 0.9 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.3 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.0 | 0.1 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 1.9 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.4 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 1.1 | GO:0005911 | cell-cell junction(GO:0005911) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 6.1 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
0.8 | 5.8 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.7 | 6.8 | GO:0019863 | IgE binding(GO:0019863) |
0.6 | 2.3 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.5 | 27.8 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.5 | 1.4 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.4 | 3.4 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
0.4 | 2.1 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.4 | 3.7 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.4 | 1.8 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.3 | 1.4 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
0.3 | 5.6 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.3 | 9.2 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.3 | 0.9 | GO:0004397 | histidine ammonia-lyase activity(GO:0004397) |
0.3 | 1.5 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.3 | 1.2 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
0.3 | 0.8 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
0.3 | 1.6 | GO:0017161 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.3 | 1.3 | GO:0004914 | interleukin-3 receptor activity(GO:0004912) interleukin-5 receptor activity(GO:0004914) |
0.2 | 1.0 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.2 | 1.4 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.2 | 0.7 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
0.2 | 0.7 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
0.2 | 47.0 | GO:0003823 | antigen binding(GO:0003823) |
0.2 | 0.6 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.2 | 1.2 | GO:0015081 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) sodium ion transmembrane transporter activity(GO:0015081) |
0.2 | 1.0 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.2 | 1.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 0.9 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.2 | 0.7 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
0.2 | 1.6 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.2 | 0.9 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.2 | 1.5 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 1.0 | GO:0042806 | fucose binding(GO:0042806) |
0.1 | 2.4 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 1.1 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 1.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 5.5 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 1.0 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.1 | 3.0 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 1.9 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 1.0 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 1.0 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 2.0 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 4.6 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.6 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.7 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.1 | 3.3 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.1 | 3.1 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 3.5 | GO:0042287 | MHC protein binding(GO:0042287) |
0.1 | 0.3 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.1 | 2.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 0.8 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.2 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 0.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.2 | GO:0004766 | spermidine synthase activity(GO:0004766) |
0.1 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.4 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
0.1 | 1.0 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.6 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 0.6 | GO:0042835 | BRE binding(GO:0042835) |
0.1 | 0.2 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.1 | 1.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.4 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.1 | 0.3 | GO:0004641 | phosphoribosylamine-glycine ligase activity(GO:0004637) phosphoribosylformylglycinamidine cyclo-ligase activity(GO:0004641) phosphoribosylglycinamide formyltransferase activity(GO:0004644) |
0.1 | 1.6 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 1.1 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.1 | 0.8 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 1.0 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.1 | 0.4 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.1 | 3.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 1.1 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 1.4 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 0.5 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 1.4 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.3 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 0.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.3 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.1 | 1.8 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 1.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 1.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 1.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.3 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) aromatase activity(GO:0070330) |
0.1 | 0.2 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
0.1 | 5.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 1.1 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 0.6 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.1 | 0.4 | GO:0005119 | smoothened binding(GO:0005119) |
0.1 | 1.3 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.4 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 0.5 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.0 | 0.5 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.6 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.0 | 0.2 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
0.0 | 1.3 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.0 | 0.6 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.5 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.3 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.0 | 0.1 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.0 | 0.1 | GO:0097689 | iron channel activity(GO:0097689) |
0.0 | 0.3 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.2 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.1 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.0 | 0.6 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.2 | GO:1902444 | riboflavin binding(GO:1902444) |
0.0 | 1.5 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.5 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.0 | 0.2 | GO:0016213 | linoleoyl-CoA desaturase activity(GO:0016213) |
0.0 | 4.5 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 2.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.2 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.0 | 0.4 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.0 | 0.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.3 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.5 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.0 | 0.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.2 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.0 | 0.8 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.3 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.7 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.0 | 0.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.0 | 0.3 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.0 | 0.3 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 2.3 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.7 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.0 | 3.1 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.1 | GO:0050146 | nucleoside phosphotransferase activity(GO:0050146) |
0.0 | 0.9 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 3.6 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.0 | 0.6 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.2 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.0 | 0.3 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.0 | 0.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.0 | 0.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.0 | 0.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 5.8 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.2 | GO:0043426 | MRF binding(GO:0043426) |
0.0 | 0.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.4 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.0 | 0.2 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 1.7 | GO:0003700 | transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.8 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.0 | 0.6 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 1.3 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.5 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.4 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.3 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.0 | 0.0 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.0 | 0.5 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.4 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.5 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.2 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.0 | 0.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 1.3 | GO:0016279 | protein-lysine N-methyltransferase activity(GO:0016279) |
0.0 | 0.3 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.9 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 1.0 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.2 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.8 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.0 | GO:0036393 | thiocyanate peroxidase activity(GO:0036393) |
0.0 | 0.1 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.0 | 0.3 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 4.0 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.0 | 0.6 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 15.5 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 21.6 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.2 | 4.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 4.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 6.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 1.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 3.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 2.7 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 6.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 3.0 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 3.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 1.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 2.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 5.7 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 1.7 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 1.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 3.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 1.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 1.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 2.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.8 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.7 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 1.6 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.8 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 1.8 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 1.0 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 1.0 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.8 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.1 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.4 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 1.0 | PID CMYB PATHWAY | C-MYB transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 22.0 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.2 | 5.8 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.2 | 4.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 17.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 7.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 8.4 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 2.6 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 3.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 2.1 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 3.4 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 4.3 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 2.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 1.6 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 1.6 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 2.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 1.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 1.4 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.1 | 1.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 1.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 5.8 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.0 | 0.9 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 1.9 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 1.1 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 1.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 2.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.7 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 1.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 1.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 1.8 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.4 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.0 | 0.8 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 2.5 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.8 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.0 | 0.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 1.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 1.9 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.0 | 1.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 2.8 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 0.3 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 0.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 1.4 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.8 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.2 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 1.5 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.0 | 0.3 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.6 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 2.5 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.3 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 2.0 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.6 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |